
    
      This is a prospective, randomized, double-blind controlled clinical trial. Written informed
      consent will be obtained from patients. Patients will be randomly assigned using the sealed
      envelope technique into 2 equal groups:

      Group 1: Patients will receive 10 mg metoclopramide with 4mg ondansetron before induction of
      general anesthesia.

      Group 2: Patients will receive 10 mg metoclopramide before induction of general anesthesia.
    
  